With Early-Cancer Detection Technology, Delfi Diagnostics Looks to Beat Out Guardant Health, Illumina’s Grail and Others
Illumina has deep pockets, Guardant Health has deep experience. But this company with a growing team in Palo Alto says it will be able to offer early-cancer detection for less.
Read the full article at: www.bizjournals.com
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
